Outlook Therapeutics Inc (OTLK)
6.04
-0.01
(-0.17%)
USD |
NASDAQ |
Nov 04, 16:00
6.055
+0.02
(+0.25%)
After-Hours: 20:00
Outlook Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2019 | -1.057 |
| June 30, 2019 | -8.41 |
| March 31, 2019 | -0.5362 |
| December 31, 2018 | -0.6434 |
| September 30, 2018 | -0.8629 |
| June 30, 2018 | -1.905 |
| March 31, 2018 | -1.136 |
| December 31, 2017 | -2.161 |
| September 30, 2017 | -0.5874 |
| Date | Value |
|---|---|
| June 30, 2017 | -0.5651 |
| March 31, 2017 | -0.4274 |
| December 31, 2016 | -0.4511 |
| September 30, 2016 | -1.437 |
| June 30, 2016 | 4.948 |
| March 31, 2016 | -0.6332 |
| December 31, 2015 | -1.134 |
| September 30, 2015 | -0.695 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Imunon Inc | -- |
| Cormedix Inc | 0.00 |
| Brainstorm Cell Therapeutics Inc | -- |
| Predictive Oncology Inc | 0.0676 |
| NovaBay Pharmaceuticals Inc | -1.128 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 47.09M |
| Total Liabilities (Quarterly) | 130.77M |
| Shareholders Equity (Quarterly) | -83.67M |